John E. McKinnon

2.2k total citations
34 papers, 530 citations indexed

About

John E. McKinnon is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, John E. McKinnon has authored 34 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Immunology. Recurrent topics in John E. McKinnon's work include HIV/AIDS drug development and treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and HIV Research and Treatment (7 papers). John E. McKinnon is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and HIV Research and Treatment (7 papers). John E. McKinnon collaborates with scholars based in United States, United Kingdom and Switzerland. John E. McKinnon's co-authors include Heather J. Shenkman, Scott Kaatz, David Nori, Keisha R. Sandberg, Peter A. McCullough, John W. Mellors, Susan Swindells, Kathleen Maksimowicz‐McKinnon, Timothy Wilkin and José Ramón Arribas and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

John E. McKinnon

29 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. McKinnon United States 13 217 213 129 51 48 34 530
David Hrncir United States 5 307 1.4× 257 1.2× 23 0.2× 45 0.9× 23 0.5× 9 447
Giuliano Stagni Italy 13 120 0.6× 53 0.2× 60 0.5× 244 4.8× 55 1.1× 42 508
Gaetano Maffongelli Italy 13 263 1.2× 25 0.1× 85 0.7× 162 3.2× 29 0.6× 29 427
Julián Olalla Spain 12 232 1.1× 29 0.1× 64 0.5× 154 3.0× 34 0.7× 69 534
Miriam Gargiulo Italy 8 167 0.8× 48 0.2× 124 1.0× 48 0.9× 14 0.3× 19 343
Naoki Yanagisawa Japan 11 170 0.8× 23 0.1× 66 0.5× 114 2.2× 16 0.3× 63 435
Alaka Deshpande India 14 387 1.8× 25 0.1× 333 2.6× 210 4.1× 42 0.9× 52 702
J.L. Pellegrin France 12 208 1.0× 19 0.1× 128 1.0× 101 2.0× 46 1.0× 27 463
Montserrat Sala Spain 9 137 0.6× 53 0.2× 72 0.6× 102 2.0× 5 0.1× 16 340
Kara W Chew United States 15 193 0.9× 25 0.1× 78 0.6× 283 5.5× 43 0.9× 49 577

Countries citing papers authored by John E. McKinnon

Since Specialization
Citations

This map shows the geographic impact of John E. McKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. McKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. McKinnon more than expected).

Fields of papers citing papers by John E. McKinnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. McKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. McKinnon. The network helps show where John E. McKinnon may publish in the future.

Co-authorship network of co-authors of John E. McKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of John E. McKinnon. A scholar is included among the top collaborators of John E. McKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. McKinnon. John E. McKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Hwanhee, Kevin J. Anstrom, Susan Halabi, et al.. (2023). Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials. BMJ Open. 13(6). e065305–e065305. 4 indexed citations
2.
McKinnon, John E., Cláudia Murta de Oliveira, Dongzi Yu, et al.. (2023). Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial. Clinical and Translational Science. 16(12). 2640–2653. 10 indexed citations
3.
Yao, Yi, Kalpana Subedi, Tingting Liu, et al.. (2022). Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes. Cell Discovery. 8(1). 89–89. 13 indexed citations
4.
Wang, Dee Dee, William W. O’Neill, Marcus Zervos, et al.. (2021). Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare Workers. Journal of Occupational and Environmental Medicine. 63(6). 476–481. 8 indexed citations
5.
McKinnon, John E., et al.. (2021). Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study. International Journal of Infectious Diseases. 116. 167–173. 6 indexed citations
6.
Maksimowicz‐McKinnon, Kathleen, et al.. (2021). Subclinical CMV viremia is associated with increased nosocomial infections and prolonged hospitalization in patients with systemic autoimmune diseases. Journal of Clinical Virology. 140. 104849–104849. 4 indexed citations
7.
Wang, Dee Dee, Kelly Malette, Guson Kang, et al.. (2020). Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19. Current Cardiology Reviews. 17(3). 319–327. 10 indexed citations
8.
Gudipati, Smitha, et al.. (2020). Descriptive Analysis of Patients Living With HIV Affected by COVID-19. JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(2). 123–126. 25 indexed citations
9.
Veve, Michael P., Susan L. Davis, Amy M. Williams, John E. McKinnon, & Tamer Ghanem. (2017). Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncology. 74. 181–187. 28 indexed citations
10.
McKinnon, John E. & Kathleen Maksimowicz‐McKinnon. (2015). Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications. Translational research. 167(1). 46–60. 20 indexed citations
11.
Cillo, Anthony R., Christina M. Lalama, John E. McKinnon, et al.. (2015). Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS. 29(16). 2121–2129. 21 indexed citations
12.
McKinnon, John E., Robbie B. Mailliard, Susan Swindells, et al.. (2014). Baseline Natural Killer and T Cell Populations Correlation with Virologic Outcome after Regimen Simplification to Atazanavir/Ritonavir Alone (ACTG 5201). PLoS ONE. 9(5). e95524–e95524. 1 indexed citations
13.
McKinnon, John E., Rafaël Delgado, Federico Pulido, et al.. (2011). Single Genome Sequencing of HIV-1 Gag and Protease Resistance Mutations at Virologic Failure during the Ok04 Trial of Simplified versus Standard Maintenance Therapy. Antiviral Therapy. 16(5). 725–732. 16 indexed citations
14.
Wilkin, Timothy, John E. McKinnon, A. Gregory DiRienzo, et al.. (2009). Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes. The Journal of Infectious Diseases. 199(6). 866–871. 44 indexed citations
15.
McKinnon, John E., José Ramón Arribas, Federico Pulido, Rafaël Delgado, & John W. Mellors. (2006). The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone. AIDS. 20(18). 2331–2335. 17 indexed citations
16.
McCullough, Peter A., Akshay Khandelwal, John E. McKinnon, et al.. (2005). Outcomes and Prognostic Factors of Systolic as Compared With Diastolic Heart Failure in Urban America. Congestive Heart Failure. 11(1). 6–11. 25 indexed citations
17.
McKinnon, John E.. (2005). A painless introduction to pharmacology. Part 3: adverse drug events. Nurse Prescribing. 3(1). 28–34.
18.
McKinnon, John E., Heather J. Shenkman, David Nori, et al.. (2002). Epidemiology of systolic and diastolic dysfunction heart failure in 3,471 urban patients. Journal of the American College of Cardiology. 39. 192–192. 1 indexed citations
19.
McKinnon, John E., et al.. (1987). Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial.. PubMed. 3(3). 105–10. 2 indexed citations
20.
McKinnon, John E.. (1974). A glimpse of medicine in China.. PubMed. 79(510). 742–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Hrncir Breakdown of academic impact, for papers by Giuliano Stagni Breakdown of academic impact, for papers by Gaetano Maffongelli Breakdown of academic impact, for papers by Julián Olalla Breakdown of academic impact, for papers by Miriam Gargiulo Breakdown of academic impact, for papers by Naoki Yanagisawa Breakdown of academic impact, for papers by Alaka Deshpande Breakdown of academic impact, for papers by J.L. Pellegrin Breakdown of academic impact, for papers by Montserrat Sala Breakdown of academic impact, for papers by Kara W Chew
Rankless by CCL
2026